Frontier Medicines Funding & Investors
South San Francisco, CA
Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
frontiermeds.comTotal Amount Raised: $344,000,000
Frontier Medicines Funding Rounds
Series C
$20,000,000
Series C Investors
ArrowMark Colorado HoldingsDeep Track CapitalSeries C
$80,000,000
Series C Investors
Deerfield ManagementDroia VenturesDCVCGalapagosRa Capital ManagementMPM CapitalSeries B
$88,500,000
Series B Investors
Woodline PartnersRa Capital ManagementMPM CapitalDeerfield ManagementSphera Global Healthcare FundArrowMark Colorado HoldingsDeep Track CapitalDroia VenturesDriehaus Capital ManagementDCVCSeries B
$88,500,000
Series B Investors
Ra Capital ManagementWoodline PartnersSphera Global Healthcare FundArrowMark Colorado HoldingsDeep Track CapitalDriehaus Capital ManagementSeries A
$67,000,000
Series A Investors
Deerfield ManagementDroia VenturesMPM CapitalRa Capital ManagementDCVCBerkeley Catalyst Fund
Funding info provided by Diffbot.